Lymphoid Enhancer Binding Factor 1 (LEF1) as a Biomarker for Wnt/Beta-Catenin Pathway Activation in the Biological Progression of Phyllodes Tumors

被引：0

作者：

Chen, Po-Han ^{[1
]}

Bossuyt, Veerle ^{[2
]}

Reisenbichler, Emily ^{[1
]}

机构：

[1] Yale Univ, New Haven, CT USA

[2] Massachusetts Gen Hosp, Woodbridge, CT USA

来源：

LABORATORY INVESTIGATION | 2019年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

123

引用

页数：2

共 50 条

[41] Inhibition of Lymphoid Enhancer Factor1(LEF1) in acute myeloid leukemia overcomes acquired cytarabine resistance. [J].

Das, Saswati ;

Illangeswaran, Raveen Stephen ;

Jebanesan, Daniel Zechariah Paul ;

Vidhyadharan, Rakhi Thalayatta ;

Bijukumar, Nayanthara Karpillymoola ;

Rajamani, Bharathi Murugan ;

Michaelis, Martin ;

Cinatl, Jindrich, Jr. ;

Mathews, Vikram ;

Velayudhan, Shaji Ramchandran ;

Balasubramanian, Poonkuzhali .

CANCER RESEARCH, 2022, 82 (12)

[42] Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial cell invasion [J].

Planutiene, Marina ;

Planutis, Kestutis ;

Holcombe, Randall F. .

VASCULAR CELL, 2011, 3

[43] THE LOWER LEVELS OF GENE EXPRESSION LEF1 (LYMPHOID ENHANCER-BINDING FACTOR-1) ARE ASSOCIATED TO FACTORS OF BAD PROGNOSIS IN ACUTE PAEDIATRIC LEUKAEMIA [J].

Roberta, Malatesta ;

Garcia Nerea, Vega ;

Aguado Camino, Estella ;

Sola Susana, Rives ;

Burriel Montserrat, Torrebadell ;

Temprano Albert, Catala ;

Moreno Ruben, Berrueco ;

Llobet Anna, Ruiz ;

Rubio Lourdes, Calvente ;

del Castillo Maria, Trabazo ;

Saladrigues Anna, Alonso ;

Meda Montserrat, Mesegue ;

Gadea Maria, Solsona ;

Guijosa Mireia, Camos .

HAEMATOLOGICA, 2016, 101 :158-159

[44] High Expression of Lymphoid Enhancer-Binding Factor 1 (LEF1) Is Related to Ummutated Status of Igvh and Is an Unfavorable Prognostic Marker for Aggressive CLL Patients [J].

Wu, Wei ;

Zhu, Huayuan ;

Fu, Yuan ;

Xu, Jiadai ;

Shen, Wenyi ;

Xu, Wei ;

Liu, Peng ;

Li, Jianyong .

BLOOD, 2012, 120 (21)

[45] Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors [J].

Lu, Haiyan ;

Allende, Daniela ;

Liu, Xiuli ;

Zhang, Yaxia .

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (10) :776-780

[46] SOX9 Inhibits the Progression of Osteonecrosis of the Femoral Head via the Activation of the Wnt/Beta-Catenin Pathway [J].

Meng, Xiangsheng ;

Zhu, Haiquan .

JOURNAL OF INVESTIGATIVE SURGERY, 2023, 36 (01)

[47] Lymphoid enhancer factor 1 (LEF1) Contributes to Hepatocellular Carcinoma Progression through Transcriptional Regulation of Epidermal-Mesenchymal Transition (EMT) Regulators and Stemness Genes [J].

Wu, Jaw-Ching ;

Chen, Chih-Li ;

Sun, Ya-Yun ;

Su, Chien-Wei .

HEPATOLOGY, 2013, 58 :1070A-1071A

[48] Oct4 induces EMT through LEF1/β-catenin dependent WNT signaling pathway in hepatocellular carcinoma [J].

Sun, Lu ;

Liu, Tianhua ;

Zhang, Shu ;

Guo, Kun ;

Liu, Yinkun .

ONCOLOGY LETTERS, 2017, 13 (04) :2599-2606

[49] Loss of expression of Wnt/Beta-catenin signaling pathway transcription factors LEF-1 and TCF-1 in a subset of peripheral T cell lymphomas [J].

Dorfman, DM ;

Greisman, H ;

Shahsafaei, A .

MODERN PATHOLOGY, 2003, 16 (01) :230A-231A

[50] Loss of expression of Wnt/beta-catenin signaling pathway transcription factors LEF-1 and TCF-1 in a subset of peripheral T cell lymphomas [J].

Dorfman, DM ;

Greisman, H ;

Shahsafaei, A .

LABORATORY INVESTIGATION, 2003, 83 (01) :230A-231A

← 1 2 3 4 5 →